--- title: "HK Market Quiet Rotation: Domino's Expansion and China Isotope's New Venture" type: "News" locale: "en" url: "https://longbridge.com/en/news/296337431.md" description: "Institutional money in 2026 is selectively pivoting toward niche Hong Kong leaders. Domino's China is validating its store economics, while Asymchem and China Isotope are signaling major expansions in the healthcare sector." datetime: "2026-08-19T10:11:42.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/296337431.md) - [en](https://longbridge.com/en/news/296337431.md) - [zh-HK](https://longbridge.com/zh-HK/news/296337431.md) generator: "portal-rs" --- # HK Market Quiet Rotation: Domino's Expansion and China Isotope's New Venture A quiet sector rotation is underway in the overlooked corners of the Hong Kong market. I'm told that ahead of the late 2026 earnings season, institutional money is selectively pivoting toward consumer recovery and niche healthcare plays. According to people familiar with the matter, despite the broader market volatility, category leaders with clear expansion roadmaps are attracting fresh liquidity. ### Domino's Pizza China (1405.HK) The company is currently outperforming most of its restaurant peers. I'm told that its expansion pace in the first quarter of 2026 has handily beaten expectations, proving out its replicable store economics. By July 2026, the company's Q2 business update showed a steady rebound in sales momentum. Having reached **4.3 billion RMB** in 2024 total revenue, management appears highly confident in the profitability outlook for the rest of the year. ### Asymchem (6821.HK) The leading CDMO player is seeing a secondary market revival. Armed with over **6.3 billion RMB** in cash and equivalents, people close to the company indicate that its overseas expansion strategy will hit key milestones later this year. While its initial public offering faced headwinds, the fundamentals remain rock solid, with its formulation CDMO business generating **284 million RMB** in H1 2025—an **18.44%** increase year-over-year. ### China Isotope & Radiation (1763.HK) Shares of the nuclear medicine giant popped over **5%** in a single session in early August 2026. The catalyst? A joint venture announced on August 2 focused on smart nuclear medicine, which I'm told is the most significant structural investment in this space recently. Paired with a **2.06%** dividend yield, it is becoming a haven for defensive capital. ### Also - **Bank of Communications (3328.HK)**: The fifth-largest mainland bank remains a steady performer. I'm told internal reviews are underway to optimize treasury reserves for the second half of the year. - **Liaoning Port (2880.HK)**: With a market cap exceeding **33 billion HKD**, the port operator is set to distribute dividends on September 1, 2026, keeping yield-hunters interested. - **Tsingtao Brewery (0168.HK)**: No major disruptions lately, though insiders suggest Q3 channel inventory clearing is nearly complete. - **Hubei Xiangjiang Electric (2619.HK)**: Renamed in January 2026, the ODM appliance maker is sitting on healthy orders, backed by **548 million RMB** in cash balances as of recent filings. - **Nanfang Communication (1617.HK)**: Demand for optical fiber cables remains flat; I'm told the firm is exploring new overseas network equipment buyers. - **3152.HK**: Continues to undergo operational realignments, with the market awaiting fresh fundamental updates later this year. *This article does not constitute investment advice.* ### Related Stocks - [01405.HK](https://longbridge.com/en/quote/01405.HK.md) - [06821.HK](https://longbridge.com/en/quote/06821.HK.md) - [01763.HK](https://longbridge.com/en/quote/01763.HK.md) - [03328.HK](https://longbridge.com/en/quote/03328.HK.md) - [02880.HK](https://longbridge.com/en/quote/02880.HK.md) - [02619.HK](https://longbridge.com/en/quote/02619.HK.md) - [01617.HK](https://longbridge.com/en/quote/01617.HK.md) ## Related News & Research - [G Sachs: China CRO/CDMO Industry Recovery Pace Clear; Positive on WUXI Series, PHARMARON, ASYMCHEM, TIGERMED and GENSCRIPT BIO](https://longbridge.com/en/news/298712241.md) - [Liaoning Port Discloses Ongoing Shortfall in Hong Kong Public Float](https://longbridge.com/en/news/281495712.md) - [Newtrend details RMB 299.8 million Jingzhou glycine project funding plan, secures RMB 220 million loan](https://longbridge.com/en/news/298323379.md) - [Guotai Haitong Sticks to Their Buy Rating for DPC Dash Limited (1405)](https://longbridge.com/en/news/297427078.md) - [Bank of Communications proposes 2026 interim dividend of RMB 0.168 per share](https://longbridge.com/en/news/297303454.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**